Comparative thromboembolic risk in atrial fibrillation patients with and without a concurrent infection

The aim of this study was to compare long-term thromboembolic risk in infection-related and non-infection-related atrial fibrillation (AF). Using Danish nationwide registries, we identified patients with first-time AF from 1996–2015 and performed a retrospective cohort study. We did a 1:1 match (upo...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2018-10, Vol.204, p.43-51
Main Authors: Gundlund, Anna, Kümler, Thomas, Olesen, Jonas Bjerring, Bonde, Anders Nissen, Gislason, Gunnar H., Torp-Pedersen, Christian, Køber, Lars, Fosbøl, Emil Loldrup
Format: Article
Language:English
Subjects:
Age
Age Factors
Aged
Aged, 80 and over
Alcohol
Anticoagulants
Anticoagulants - therapeutic use
Atrial Fibrillation - complications
Atrial Fibrillation - mortality
Cardiac arrhythmia
Cardiovascular disease
Chronic obstructive pulmonary disease
Concurrent infection
Confidence intervals
Denmark
Diabetes
Emigration
Fees & charges
Female
Fibrillation
Health risk assessment
Health risks
Heart failure
Hospitalization
Humans
Hypertension
Identification methods
Infection - complications
Infections
Kidney diseases
Liver diseases
Male
Patient Readmission
Patients
Pneumonia
Population studies
Proportional Hazards Models
Recurrence
Registries
Regression analysis
Retrospective Studies
Risk
Risk Factors
Statistical analysis
Stroke
Therapy
Thromboembolism
Thromboembolism - etiology
Thromboembolism - prevention & control
Thyroid diseases
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to compare long-term thromboembolic risk in infection-related and non-infection-related atrial fibrillation (AF). Using Danish nationwide registries, we identified patients with first-time AF from 1996–2015 and performed a retrospective cohort study. We did a 1:1 match (upon sex, age, calendar year, and oral anticoagulation (OAC) status at the beginning of follow-up) of patients with infection-related (concurrent discharge diagnosis code for infection) and non-infection-related AF. Long-term outcomes were examined using multivariable Cox regression analyses. Our study population comprised 48,644 patients equally distributed on infection-related and non-infection-related AF. In both groups, those initiated on OAC therapy were younger than those not initiated on OAC therapy (median age 77 years, interquartile range 69–83 versus median age 79 years, interquartile range 71–86). During the 1st year of follow up, infection-related AF was associated with an increased risk of thromboembolic events compared with non-infection-related AF: adjusted hazard ratio (HR) 1.44 (95% confidence interval (CI) 1.16–1.78) for those initiated on OAC therapy and HR 1.17 (95% CI 1.06–1.28) for those not initiated on OAC therapy. In both groups, OAC therapy was associated with better outcomes than no OAC therapy (HR of thromboembolic events 0.75 (95% CI 0.68–0.83) and HR 0.70 (95% CI 0.63–0.78) for patients with infection-related and non-infection-related AF, respectively). Infection was associated with an increased thromboembolic risk in patients with first-time AF. OAC therapy was associated with a similar risk-reduction in AF patients with and without a concurrent infection.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2018.07.003